Moomoo AI 已提取核心信息
The Vanguard Group has filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Ginkgo Bioworks Holdings, Inc. Class A common stock. As of December 29, 2023, The Vanguard Group owns an aggregate amount of 132,779,676 shares, representing 8.20% of the class. This filing, dated February 13, 2024, shows that The Vanguard Group has shared voting power over 461,957 shares and sole dispositive power over 130,958,928 shares, with an additional shared dispositive power over 1,820,748 shares. The filing asserts that the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing the control of the issuer.
The Vanguard Group has filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Ginkgo Bioworks Holdings, Inc. Class A common stock. As of December 29, 2023, The Vanguard Group owns an aggregate amount of 132,779,676 shares, representing 8.20% of the class. This filing, dated February 13, 2024, shows that The Vanguard Group has shared voting power over 461,957 shares and sole dispositive power over 130,958,928 shares, with an additional shared dispositive power over 1,820,748 shares. The filing asserts that the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing the control of the issuer.
Vanguard集团已向美国证券交易委员会提交了经修订的附表13G/A，表明其持有的Ginkgo Bioworks Holdings, Inc.A类普通股发生了变化。截至2023年12月29日，Vanguard集团共拥有132,779,676股股票，占该类别的8.20％。这份日期为2024年2月13日的文件显示，先锋集团对461,957股股票共享投票权，对130,958,928股股票共享唯一处置权，另外对1,820,748股股票拥有共同处置权。该文件称，这些股票是在正常业务过程中收购的，其目的不是改变或影响发行人的控制权。
Vanguard集团已向美国证券交易委员会提交了经修订的附表13G/A，表明其持有的Ginkgo Bioworks Holdings, Inc.A类普通股发生了变化。截至2023年12月29日，Vanguard集团共拥有132,779,676股股票，占该类别的8.20％。这份日期为2024年2月13日的文件显示，先锋集团对461,957股股票共享投票权，对130,958,928股股票共享唯一处置权，另外对1,820,748股股票拥有共同处置权。该文件称，这些股票是在正常业务过程中收购的，其目的不是改变或影响发行人的控制权。
有用
没用